ATRA vs CTRA · rev $128.9M vs P/E 15, rev $5.46B
Atara Biotherapeutics Inc (ATRA) versus Coterra Energy Inc (CTRA) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Coterra Energy Inc (CTRA) is a oil & gas e&p company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CTRA revenue for 2024-12-31 was $5.46B. Net income was $1.12B. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
ATRA currently screens at market cap $87.1M. CTRA currently screens at market cap $20.46B and trailing P/E 15.2.
Not investment advice. Open the ATRA and CTRA stock pages for the full models.
Not investment advice.